Ph+ acute lymphoblastic lymphoma and the immune system in hematological neoplasms.
Listen as Emeritus Prof Robin Foà brings you on the journey of Ph+ ALL management together with our host Dr Enrica Orsini. With a long career in ALL, Prof Foà runs through the history of Ph+ ALL, his experience in patient management, and then brings you up to date on the current picture in patient management.
Tune in as Prof Foà describes the breakthrough in treatment with TKI inhibitors and the introduction of the immunotherapeutic drug blinatumomab in Ph+ ALL.
Guest: Emeritus Prof. Robin Foà
Host: Dr. Enrica Orsini
Learn more:
What did you think of this podcast? Share your opinions with us…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.